Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kevin McInally"'
Publikováno v:
Toxicologic Pathology. 49:334-348
Afrezza delivers inhaled insulin using the Gen2 inhaler for the treatment of patients with type 1 and type 2 Diabetes. Afrezza was evaluated in long-term nonclinical pulmonary safety studies in 2 toxicology species. Chronic inhalation toxicology stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7fcab2fb356217ea065704281ffcdc6
https://doi.org/10.1177/0192623320960420
https://doi.org/10.1177/0192623320960420
Autor:
Dolorès Carballo, Sherwin Silo, Patricia Stotland, Myriam Triest, Kevin McInally, Patrick Normand, Frederick E. Reno, Claude A. Piché
Publikováno v:
BMC Pharmacology & Toxicology
Background Glucagon nasal powder (GNP), a novel intranasal formulation of glucagon being developed to treat insulin-induced severe hypoglycemia, contains synthetic glucagon (10 % w/w), beta-cyclodextrin, and dodecylphosphocholine. The safety of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4e2d745fbd5faff152fa7771103950e
http://europepmc.org/articles/PMC4621930
http://europepmc.org/articles/PMC4621930